X0306 4 2017-04-01 0 0001410939 Ophthotech Corp. OPHT 0001277478 SBLENDORIO GLENN C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 0 1 0 0 President, CFO and Treasurer Common Stock 2017-04-01 4 M 0 18750 A 18960 D Common Stock 2017-04-03 4 S 0 7388 3.56 D 11572 D Restricted Stock Units 2017-04-01 4 M 0 18750 0.00 D 2026-03-31 Common Stock 18750 56250 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. This total includes 210 shares acquired by the reporting person under the issuer's 2016 Employee Stock Purchase Plan on March 15, 2017. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on April 1, 2017. These shares were disposed of in multiple transactions on April 3, 2017 at actual sales prices ranging from $3.55 to $3.59 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. On April 1, 2016, the reporting person was granted an award of 75,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan. /s/ Barbara Wood, as Attorney-in-Fact for Glenn Sblendorio 2017-04-04